Purpose and Goals of the Program

• Kwaku Ohene-Frempong, M.D.
  Professor of Pediatrics
  University of Pennsylvania School of Medicine
  Director, Comprehensive Sickle Cell Center
  The Children’s Hospital of Philadelphia
  
  Click to view
   
  
  Kwaku Ohene-Frempong, M.D.
  

Hydroxyurea Therapy

• Martin H. Steinberg, M.D.
  Professor of Medicine and Pediatrics (advantages)
  Boston University School of Medicine
  Director, Center of Excellence in Sickle Cell Disease
  Boston Medical Center
  Click to view
  
  
  George Dover, M.D.
  Givens Professor of Pediatrics (limitations)
  Professor of Medicine and Oncology
  Johns Hopkins University School of Medicine
  Director, Department of Pediatrics
  Johns Hopkins University Hospital
  Click to view
  
  
  Louise Dorn, R.N., M.S.
  (family and psychosocial issues)
  Sickle Cell Project Coordinator
  University of Illinois at Chicago
  Click to view

• Robert Iannone, M.D.
  Assistant Professor of Pediatrics (advantages)
  University of Pennsylvania School of Medicine
  Division of Oncology/Section of Stem Cell Transplantation
  The Children’s Hospital of Philadelphia
  Click to view
  
  Miguel R. Abboud, M.D.
  Professor of Pediatrics (limitations)
  American University of Beirut, Beirut, Lebanon
  Director, Children’s Cancer Center of Lebanon
  Click to view
  
  Betsy Sass, R.N.
  (family and psychosocial issues)
  Pediatric Sickle Cell Program
  Medical University of South Carolina, Charleston
  Click to view
  

Blood Transfusion as Treatment for Sickle Cell Disease

• Elliott Vichinsky, M.D.,
  Professor of Pediatrics (advantages)
  University of California at San Francisco
  Director of Hematology/Oncology
  Children’s Hospital and Research Center at Oakland
  Click to view
  
  Alan Cohen, M.D.
  Professor of Pediatrics
  and Chairman, Department of Pediatrics (limitations)
  University of Pennsylvania School of Medicine
  Physician-in-Chief, The Children’s Hospital of Philadelphia
  
  Marie B. Martin, R.N.
  Hematology Nurse (family and psychosocial issues)
  Division of Hematology
  The Children’s Hospital of Philadelphia
  Click to view
  

International Aspects of Therapy for Sickle Cell Disease
(COMING SOON)

• Clarisse Lobo, M.D.
  Medical Director, HEMORIO
  Rio de Janeiro, Brazil
  

Panelist Listed Below
Click to view

Doris Wethers, M.D., Panel Chair

• Doris Wethers, M.D.
  Panel Chair
  Formerly Director, Sickle Cell Program
  St. Luke’s – Roosevelt Hospital
  Professor of Clinical Pediatrics
  Columbia University
  
  Ruthie Abney
  Administrative Specialist
  Office of Capital Access
  U.S. Small Business Administration
  Person with sickle cell disease
  
  Charles Adams, M.S.W.
  Division of Hematology
  The Children’s Hospital of Philadelphia
  Social Worker
  
  Kenneth Bridges, M.D.
  Associate Professor of Medicine
  Harvard Medical School
  Physician, Brigham & Women’s Hospital
  Adult Hematologist
  
  Mary E. Brown
  President and CEO
  Sickle Cell Disease Foundation of California
  Community-based Organization
  
  William Mentzer, M.D.
  Professor of Pediatrics, Hematology/Oncology
  University of California San Francisco
  Director Northern California Comprehensive Sickle Cell Center
  Pediatric Hematologist
  
  William Schultz, M.H.S., PA-C
  Pediatric Sickle Cell Program
  Duke University School of Medicine
  Duke University Medical Center
  Physician Assistant
  
  Marsha Treadwell, Ph.D.
  Hematology Behavioral Services Coordinator
  Departments Hematology and Psychiatry
  Children’s Hospital and Research Center at Oakland
  Psychologist
  
  Delane Weltch
  Wireless Data Systems Engineer
  Verizon Wireless
  Parent of child with sickle cell disease

Sponsorship of this Webcast Supported in Part by:

Montefiore Medical Center
www.montefiore.org